Africure Pharmaceuticals Botswana(p Pharmaceutical Import Profile — Botswana (DGFT 2022–2026)

Name: Africure Pharmaceuticals Botswana(p Pharmaceutical Import Records from India — 2 Products, $200.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Africure Pharmaceuticals Botswana(p — Pharmaceutical Importer Profile (2026) | 2 Products, $200.0K Trade | TransData Nexus

Africure Pharmaceuticals Botswana(p — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Africure Pharmaceuticals Botswana Pty Ltd is a pharmaceutical importer and distributor based in Botswana, specializing in the procurement and distribution of finished pharmaceutical formulations. The company is a subsidiary of Africure Pharmaceuticals Limited, a Mauritius-based entity committed to enhancing healthcare across Sub-Saharan Africa. Africure Pharmaceuticals Limited operates manufacturing facilities in countries such as Cameroon, Côte d'Ivoire, Namibia, and India, with distribution subsidiaries in Burkina Faso, Cameroon, and Nigeria.

In Botswana, Africure Pharmaceuticals Botswana Pty Ltd plays a pivotal role in the pharmaceutical supply chain by importing essential medications to meet the country's healthcare needs. The company's focus on finished pharmaceutical formulations ensures the availability of ready-to-use medications, thereby contributing to the efficiency and effectiveness of Botswana's healthcare system. By sourcing high-quality products from reputable manufacturers, Africure Pharmaceuticals Botswana Pty Ltd supports the nation's efforts to provide accessible and affordable healthcare solutions to its population.

2Distribution Network

Africure Pharmaceuticals Botswana Pty Ltd operates its distribution network from its facility located at Plot 1090, Selokwaneng Industrial Site, Tlokweng, Botswana. The company's logistics capabilities are designed to ensure the timely and efficient delivery of pharmaceutical products across Botswana. While specific details about warehouse locations and shipping routes are not publicly disclosed, Africure's strategic positioning within the Selokwaneng Industrial Site suggests a well-organized infrastructure capable of supporting nationwide distribution.

The company's geographic coverage primarily focuses on the domestic market within Botswana. However, Africure Pharmaceuticals Limited's broader operations across Sub-Saharan Africa indicate potential for regional distribution and collaboration. This regional presence may facilitate the sharing of resources and expertise, enhancing the overall efficiency and reach of Africure Pharmaceuticals Botswana Pty Ltd's distribution network.

3Industry Role

Africure Pharmaceuticals Botswana Pty Ltd serves as a pharmaceutical importer and distributor within Botswana's healthcare sector. By focusing on the importation of finished pharmaceutical formulations, the company ensures the availability of essential medications in the country. This role is crucial in addressing the healthcare needs of the population, particularly in providing access to treatments for various medical conditions.

The company's position in the supply chain allows it to bridge the gap between international pharmaceutical manufacturers and the local market. By sourcing high-quality products from reputable suppliers, Africure Pharmaceuticals Botswana Pty Ltd contributes to the overall quality and reliability of the pharmaceutical products available in Botswana. This intermediary role is vital in maintaining a steady supply of medications, thereby supporting the effectiveness of the nation's healthcare system.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Africure Pharmaceuticals Botswana(p

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Africure Pharmaceuticals Botswana Pty Ltd's sourcing strategy exhibits a high degree of concentration, with a total import value of $200,000 USD from India across four shipments. The imported products are exclusively antiviral and HIV medications, specifically Dolutegravir and Tenofovir, each accounting for $100,000 USD. This concentration indicates a strategic focus on sourcing critical HIV treatments from a single supplier.

While this sourcing approach may offer benefits such as streamlined procurement processes and potentially favorable pricing, it also introduces risks associated with supplier dependency. Any disruptions in the supplier's operations, such as production delays or regulatory issues, could directly impact Africure Pharmaceuticals Botswana Pty Ltd's ability to meet local demand. Therefore, it is essential for the company to assess and manage these risks proactively to ensure a consistent and reliable supply of essential medications.

The shipment data reveals a stable relationship between Africure Pharmaceuticals Botswana Pty Ltd and its Indian supplier, with consistent import activities over the observed period. This stability suggests effective collaboration and mutual trust, which are crucial for maintaining a steady supply chain. However, the lack of diversification in sourcing may limit the company's flexibility in responding to market changes or supply chain disruptions.

2Supply Chain Resilience

Importing Pharmaceuticals into Botswana — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Botswana

1Regulatory Authority & Framework

In Botswana, the primary regulatory authority overseeing pharmaceutical imports and distribution is the Botswana Medicines Regulatory Authority (BoMRA). BoMRA is responsible for ensuring the safety, efficacy, and quality of medicines available in the country. The key legislation governing pharmaceutical imports includes the Medicines and Related Substances Act, which outlines the requirements for the registration, importation, and distribution of pharmaceutical products.

The marketing authorization pathway for Indian generics involves submitting a comprehensive dossier to BoMRA, demonstrating compliance with the Medicines and Related Substances Act. This process includes providing evidence of Good Manufacturing Practice (GMP) certification, product quality data, and clinical efficacy studies. Upon successful evaluation, BoMRA grants marketing authorization, allowing the product to be legally imported and distributed within Botswana.

2Import Licensing & GMP

Import licensing requirements in Botswana stipulate that all pharmaceutical products must be registered with BoMRA before importation. This registration process ensures that imported medicines meet the necessary safety, efficacy, and quality standards. Manufacturers seeking to export to Botswana must hold valid GMP certificates recognized by BoMRA, such as those issued by the World Health Organization (WHO) or the Pharmaceutical Inspection Co-operation Scheme (PIC/S).

Africure Pharmaceuticals Botswana(p — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Africure Pharmaceuticals Botswana Pty Ltd's product strategy focuses on the importation of antiviral and HIV medications, specifically Dolutegravir and Tenofovir. This focus aligns with the high prevalence of HIV/AIDS in Sub-Saharan Africa, including Botswana, where access to effective antiretroviral therapies is crucial for public health. By prioritizing these therapeutic areas, Africure Pharmaceuticals Botswana Pty Ltd addresses a significant healthcare need, contributing to the improvement of health outcomes in the region.

The market demand for these medications is driven by the ongoing efforts to combat HIV/AIDS, the need for affordable treatment options, and the desire to improve the quality of life for individuals living with the virus. Africure Pharmaceuticals Botswana Pty Ltd's strategic focus on these products positions the company as a key player in the fight against HIV/AIDS in Botswana, supporting national health initiatives and contributing

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Africure Pharmaceuticals Botswana(p

What products does Africure Pharmaceuticals Botswana(p import from India?

Africure Pharmaceuticals Botswana(p imports 2 pharmaceutical products across 1 categories. Top imports: Dolutegravir ($100.0K), Tenofovir ($100.0K).

What is Africure Pharmaceuticals Botswana(p's total pharmaceutical import value?

Africure Pharmaceuticals Botswana(p's total pharmaceutical import value from India is $200.0K, based on 4 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Africure Pharmaceuticals Botswana(p focus on?

Africure Pharmaceuticals Botswana(p imports across 1 categories. The largest: Antiviral & HIV Medications (100.0%).

Get Full Africure Pharmaceuticals Botswana(p Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Africure Pharmaceuticals Botswana(p

Africure Pharmaceuticals Botswana(p — Import Portfolio & Supplier Network

What Products Does Africure Pharmaceuticals Botswana(p Import?

Top Products by Import Value

Africure Pharmaceuticals Botswana(p Therapeutic Categories — 1 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Related Trade Data

Need Detailed Data?